New Issue: Orbital Catastrophe Ahead? Read Now

Predisposition for Addiction

Join Our Community of Science Lovers!

Many people assume that an addict’s substance abuse is responsible for the damage done to his or her brain. New research shows that some of that “damage” may have been there to begin with.

Chronic drug users have fewer dopamine D2 receptors than nonusers in the reward pathways of their brain, which often makes them less sensitive to natural pleasures such as food and attractive mates. Scientists believe this receptor deficit may reinforce addiction by causing users to seek from drugs what they are unable to get naturally—the “high” caused by a surge of dopamine.

Now Jeffrey Dalley and his colleagues at the University of Cambridge have shown that some people may be born with an abnormally low D2 receptor count, predisposing them to impulsive behavior and drug addiction.


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


The team compared the brains of six impulsive rats and six normal rats and then allowed the animals to self-administer cocaine. The impulsive rats became addicted more quickly than their nonimpulsive lab mates, and they showed a significantly lower number of D2 receptors in the ventral striatum, a brain region associated with reward anticipation and craving. The researchers found no differences in the dorsolateral striatum, an area involved in compulsive drug-seeking behavior. A decrease in D2 receptors within this brain area, according to past findings, is seen most commonly after habitual drug use.

“This last point is crucial because it suggests that progressive drug use produces progressive changes in the brain,” Dalley says.

The scientists proposed a hypothesis: some drug addicts are born with a localized reduction of D2 receptors in the ventral striatum. This anomaly predisposes them to high levels of impulsivity, which may lead to their initial experimentation with drugs. Long-term drug abuse, in turn, may cause damage in the dorsolateral striatum and other parts of the brain’s reward pathway, causing addicts to compulsively seek out drugs.

If the researchers are correct, D2 receptors may one day be used to identify people at high risk for drug abuse.

SA Mind Vol 18 Issue 3This article was published with the title “Predisposition for Addiction” in SA Mind Vol. 18 No. 3 (), p. 13
doi:10.1038/scientificamericanmind0607-13b

Subscribe to Support Independent Journalism

Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.

When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.

Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber

Thank you,

Jeanna Bryner, Editor in Chief, Scientific American

Subscribe